Recent studies have shown that the serum IL-6 level in patients with MDS–MLD was significantly higher than that in patients with MDS–SLD and MDS–RS, but there is no significant difference between different IPSS-R group. This evidence concerns the gene IL6 and myelodysplastic syndrome.